Article Details
Retrieved on: 2024-11-12 11:53:27
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the FDA's clearance of OTC continuous glucose monitors and their potential public health implications. While benefiting people with diabetes, their utility for the non-diabetic population remains debated without sufficient research backing. Experts emphasize educating primary care professionals on interpreting CGM data, given limited endocrinologist availability. This relates to public health through improved medical monitoring and early diagnosis of conditions like prediabetes.
Article found on: www.medscape.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here